High-molecular-weight (HMW)
kininogen was purified from guinea-pig plasma by measuring its ability to correct the prolonged clotting time in human HMW
kininogen deficient plasma (
Fitzgerald trait). The purified HMW
kininogen demonstrated a homogeneous band in disc gel electrophoresis in the presence of
sodium dodecyl sulfate under reducing or non-reducing conditions with an apparent molecular weight of 100,000.
Kinin released from HMW
kininogen by treatment with guinea-pig
plasma kallikrein was identified as
bradykinin by reverse-phase HPLC and
amino-acid analysis. The capacity of HMW
kininogen as a
thiol-
proteinase inhibitor was realized by its dose-dependent inhibitory activity to
papain. The Ki value for
papain was estimated to be 42 pM. The
kinin-free HMW
kininogen maintained the inhibitor and
clotting-factor activities with similar capacities to those of the HMW
kininogen molecule. Heavy chain (H-chain) and light chain (L-chain) of HMW
kininogen were prepared from reduced and alkylated
kinin-free HMW
kininogen by HPLC. The S-alkylated H-chain, but not L-chain, demonstrated the inhibitor activity with the Ki value 6.9 nM for
papain, whereas the S-alkylated L-chain, but not H-chain, maintained the clotting activity one-third of the capacity of HMW
kininogen. Specific
antibodies recognized HMW
kininogen, but also a probable
low-molecular-weight kininogen(s) with an apparent molecular weight of 60,000 in the guinea-pig plasma. All of these properties are consistent with the reports on human, bovine and rat HMW
kininogen.